November 2019
GDPR for life science follow the US’ data privacy step

On 5th November 2019, two representatives from California (Silicon Valley, USA) proposed the implementation of an ‘American version’ of GDPR. This proposed law, known as the Online Privacy Act, would have the same goal as the General Data Protection Regulation (GDPR): the protection of citizens. Universal Medica Group, through the concept we have developed ‘GDPR for life science’, ensures the management and protection of data,

20

Nov
2019
Comments Off on GDPR for life science follow the US’ data privacy step
Meeting point at DIA Europe 2019 – 20 and 21 November – Lisbon Portugal

In march 2019, Universal Medica Group and EVERSANA have entered into a partnership to provide medical information and pharmacovigilance services throughout Europe, Asia and North, Central and South America. This strategic collaboration meets the evolving needs of Global clients. As a single, integrated service partner EVERSANA and Universal Medica Group deliver programs with the infrastructure, technology, worflows and clinical staffing needed to effectively and efficiently

19

Nov
2019
Comments Off on Meeting point at DIA Europe 2019 – 20 and 21 November – Lisbon Portugal
March 2019
UNIVERSAL MEDICA GROUP and EVERSANA announce global medical information and pharmacovigilance service partnership

Universal Medica Group and EVERSANA today are pleased to announce that they have entered into a definitive partnership, increasing their global footprint and enhancing their expertise in the life sciences and healthcare industry. Universal Medica Group, an expert in healthcare and pharmaceutical services, will partner with EVERSANA, the leading independent provider of full commercial services to the life science industry, and together, the companies take

21

Mar
2019
Comments Off on UNIVERSAL MEDICA GROUP and EVERSANA announce global medical information and pharmacovigilance service partnership
August 2018
BBac’s acquisition by UNIVERSAL MEDICA GROUP

Universal Medica Group (UMG) has reached a new stage in its development with the acquisition of BBac, a company specializing in pharmacovigilance and safety in the healthcare industry. This acquisition is part of the “Horizon 2020” strategic plan, which responds to the industry transformations and to needs of healthcare industry evolutions to promote the healthcare products proper use, safety and efficacy for patients’ benefit. An

21

Aug
2018
Comments Off on BBac’s acquisition by UNIVERSAL MEDICA GROUP
April 2018
Interview – Emmanuelle B. : Pharmacovigilance Manager

Presentation I am a pharmacist (PharmD) and I have a University thesis in PharmacoEpidemiology (PhD). Afterwards, I worked during 15 years as a practitioner in the Regional Center of Pharmacovigilance (CRPV) of Toulouse before joining Universal Medica as Pharmacovigilance Manager (PV). During these 15 years, I carried out numerous appraisals for the ANSM, in particular in oncology. What is your role as a Pharmacovigilance Manager?

20

Apr
2018
Comments Off on Interview – Emmanuelle B. : Pharmacovigilance Manager
DIA Europe 2018 – 17 & 19 Avril, Bazel Switzerland

Universal Medica your partner in medical communication will be present at this year’s DIA conference in Basel, Switzerland. We would like to share with you our vision of the evolution of Medical Affairs and listen to your current and future needs in this evolving environment. The future of drug safety management is changing and becoming a crucial key topic in the lifecycle management of a product. Efficacy,

13

Apr
2018
Comments Off on DIA Europe 2018 – 17 & 19 Avril, Bazel Switzerland
March 2018
Webinar : train, certify and assess your medical visitors’ regulatory skills

What is the certification of information activities for promotional purposes? The new Charter on Information provided for the Promotion of Medicines of 2014 replaces the medical visit charter of 2004. It requires collaborators responsible for the promotion of medicines to be trained with 7 regulatory modules that guarantee proficiency in quality information practices through prospecting and canvassing. These modules will focus on: – The medicines:

25

Mar
2018
Comments Off on Webinar : train, certify and assess your medical visitors’ regulatory skills
Webinar: Online reputation and crisis management on social media

What is an online reputation? An online reputation is the image a company, brand, service, organization or individual projects through their behavior and the content they communicate. All of these informations are transmitted through social media, online platforms, and other content published online. If positive, this information will help maintain a good reputation as well as a competitive advantage. If negative, it will create a

12

Mar
2018
Comments Off on Webinar: Online reputation and crisis management on social media
February 2018
Innovation Prize 2018 – Call for projects – Deadline on 30th April 2018

For its 10th consecutive year, Universal Biotech, , a Universal Medica Group division, is launching its Innovation Prize. Are you a young startup or an academic research group? Are you currently developing an innovative project in the field of Biotech, Medtech or -health? Then the Innovation Prize 2018 is the right competition for you! Submit online Three prizes will be awarded Three prizes will be

23

Feb
2018
Comments Off on Innovation Prize 2018 – Call for projects – Deadline on 30th April 2018
Public Survey About Cancer Care – Santé sur le Net

Cherry for Life Science, a division of Universal Medica Group, is launching a full-scale online survey about cancer care on its French healthcare website, Santé sur le Net. The purpose of the survey is to better understand awareness level and the perceived impact of this disease in France, with nearly 400,000 new cases of cancer in 2017. Complete the survey Our approach Every week, our

22

Feb
2018
Comments Off on Public Survey About Cancer Care – Santé sur le Net

February 2018

Page 1 of 41234